Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19.
COVID-19
echocardiography
postacute COVID syndrome
Journal
Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
12
07
2022
received:
01
06
2022
accepted:
12
07
2022
pubmed:
4
8
2022
medline:
19
10
2022
entrez:
3
8
2022
Statut:
ppublish
Résumé
Cardiac function may be impaired during and early after hospitalization for COVID-19, but little is known about the progression of cardiac dysfunction and the association with postacute COVID syndrome (PACS). In a multicenter prospective cohort study, patients who had been hospitalized with COVID-19 were enrolled and comprehensive echocardiography was performed 3 and 12 months after discharge. Twenty-four-hour electrocardiogram (ECG) was performed at 3 and 12 months in patients with arrhythmias at 3 months. In total, 182 participants attended the 3 and 12 months visits (age 58 ± 14 years, 59% male, body mass index 28.2 ± 4.2 kg/m Following COVID-19, cardiac structure and function remained unchanged from 3 to 12 months after the index hospitalization, irrespective of COVID-19 severity and presence of persistent dyspnea. These results suggest that progression of cardiac dysfunction after COVID-19 is rare and unlikely to play an important role in PACS.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiac function may be impaired during and early after hospitalization for COVID-19, but little is known about the progression of cardiac dysfunction and the association with postacute COVID syndrome (PACS).
METHODS
METHODS
In a multicenter prospective cohort study, patients who had been hospitalized with COVID-19 were enrolled and comprehensive echocardiography was performed 3 and 12 months after discharge. Twenty-four-hour electrocardiogram (ECG) was performed at 3 and 12 months in patients with arrhythmias at 3 months.
RESULTS
RESULTS
In total, 182 participants attended the 3 and 12 months visits (age 58 ± 14 years, 59% male, body mass index 28.2 ± 4.2 kg/m
CONCLUSION
CONCLUSIONS
Following COVID-19, cardiac structure and function remained unchanged from 3 to 12 months after the index hospitalization, irrespective of COVID-19 severity and presence of persistent dyspnea. These results suggest that progression of cardiac dysfunction after COVID-19 is rare and unlikely to play an important role in PACS.
Identifiants
pubmed: 35920837
doi: 10.1002/clc.23891
pmc: PMC9538691
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1044-1052Subventions
Organisme : Akershus Universitetssykehus
Organisme : Landsforeningen for Hjerte- og Lungesyke
Informations de copyright
© 2022 The Authors. Clinical Cardiology published by Wiley Periodicals, LLC.
Références
Sandoval Y, Januzzi JJL, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244-1258. doi:10.1016/j.jacc.2020.06.068
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3
Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiology. 2020;5(7):802-810. doi:10.1001/jamacardio.2020.0950
Omland T, Prebensen C, Røysland R, et al. Established cardiovascular biomarkers provide limited prognostic information in unselected patients hospitalized with COVID-19. Circulation. 2020;142(19):1878-1880. doi:10.1161/circulationaha.120.050089
Li Y, Li H, Zhu S, et al. Prognostic value of right ventricular longitudinal strain in patients with COVID-19. JACC Cardiovasc Imaging. 2020;13(11):2287-2299. doi:10.1016/j.jcmg.2020.04.014
Lassen MCH, Skaarup KG, Lind JN, et al. Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study. ESC Heart Fail. 2020;7:4189-4197. doi:10.1002/ehf2.13044
Baycan OF, Barman HA, Atici A, et al. Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography. Int J Cardiovasc Imaging. 2021;37(1):135-144. doi:10.1007/s10554-020-01968-5
Bursi F, Santangelo G, Sansalone D, et al. Prognostic utility of quantitative offline 2D-echocardiography in hospitalized patients with COVID-19 disease. Echocardiography. 2020;37(12):2029-2039. doi:10.1111/echo.14869
Li R, Wang H, Ma F, et al. Widespread myocardial dysfunction in COVID-19 patients detected by myocardial strain imaging using 2-D speckle-tracking echocardiography. Acta Pharmacol Sin. 2021;42:1567-1574. doi:10.1038/s41401-020-00595-z
Szekely Y, Lichter Y, Taieb P, et al. Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation. 2020;142(4):342-353. doi:10.1161/CIRCULATIONAHA.120.047971
Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19. JAMA Cardiol. 2020;5(11):1265-1273. doi:10.1001/jamacardio.2020.3557
Clark DE, Parikh A, Dendy JM, et al. COVID-19 myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR). Circulation. 2021;143(6):609-612. doi:10.1161/CIRCULATIONAHA.120.052573
Lassen MCH, Skaarup KG, Lind JN, et al. Recovery of cardiac function following COVID -19 - ECHOVID -19: A prospective longitudinal cohort study. Eur J Heart Fail. 2021;23:1903-1912. doi:10.1002/ejhf.2347
Moody WE, Liu B, Mahmoud-Elsayed HM, et al. Persisting adverse ventricular remodeling in COVID-19 survivors: a longitudinal echocardiographic study. J Am Soc Echocardiogr. 2021;34(5):562-566. doi:10.1016/j.echo.2021.01.020
Ingul CB, Grimsmo J, Mecinaj A, et al. Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc. 2022;11(3):e023473. doi:10.1161/JAHA.121.023473
Catena C, Colussi G, Bulfone L, Da Porto A, Tascini C, Sechi LA. Echocardiographic comparison of COVID-19 patients with or without prior biochemical evidence of cardiac injury after recovery. J Am Soc Echocardiogr. 2021;34(2):193-195. doi:10.1016/j.echo.2020.10.009
Sechi LA, Colussi G, Bulfone L, et al. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge. Clin Res Cardiol. 2021;110(7):1063-1072. doi:10.1007/s00392-020-01800-z
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585
Lerum TV, Aaløkken TM, Brønstad E, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021;57(4):2003448. doi:10.1183/13993003.03448-2020
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of, Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(4):412. doi:10.1093/ehjci/jew041
Dalen H, Thorstensen A, Vatten LJ, Aase SA, Stoylen A. Reference values and distribution of conventional echocardiographic Doppler measures and longitudinal tissue Doppler velocities in a population free from cardiovascular disease. Circ Cardiovasc Imaging. 2010;3(5):614-622. doi:10.1161/circimaging.109.926022
Williams N. The MRC breathlessness scale. Occup Med (Lond). 2017;67(6):496-497. doi:10.1093/occmed/kqx086
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines. Eur Heart J. 2016;37(36):2768-2801. doi:10.1093/eurheartj/ehw211
Barman HA, Atici A, Tekin EA, et al. Echocardiographic features of patients with COVID-19 infection: a cross-sectional study. Int J Cardiovasc Imaging. 2021;37(3):825-834. doi:10.1007/s10554-020-02051-9
Hiremath PG, Goerlich E, Mukherjee M, et al. Recovery of left ventricular dysfunction in hospitalized patients with COVID-19. J Am Coll Cardiol. 2021;77(18):3036.
Churchill TW, Bertrand PB, Bernard S, et al. Echocardiographic features of COVID-19 illness and association with cardiac biomarkers. J Am Soc Echocardiogr. 2020;33(8):1053-1054. doi:10.1016/j.echo.2020.05.028
Catena C. Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery; 2021.
Tangen J, Aukrust P, Barrat-Due A, et al. Cardiac function is normal in most patients recovered from COVID-19. Eur Heart J. 2021;42(suppl_1):265. doi:10.1093/eurheartj/ehab724.0265
Gao Y-P, Zhou W, Huang P-N, et al. Normalized cardiac structure and function in COVID-19 survivors late after recovery. Front Cardiovasc Med. 2021;8:756790. doi:10.3389/fcvm.2021.756790
Myhre PL, Heck SL, Skranes JB, et al. Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity. Am Heart J. 2021;242:61-70. doi:10.1016/j.ahj.2021.08.001
Cassar MP, Tunnicliffe EM, Petousi N, et al. Symptom persistence despite improvement in cardiopulmonary health - insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine. 2021;41:101159. doi:10.1016/j.eclinm.2021.101159
Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nature Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z
Lledó G, Sellarés J, Brotons C, et al. finition, Impact and Management. Col·legi Oficial de Metges de Barcelona (COMB). Post-Acute COVID Syndrome (PACS); 2021.
Skjørten I, Ankerstjerne OAW, Trebinjac D, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. 2021;58(2):2100996. doi:10.1183/13993003.00996-2021
Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart failure. 2021;9(12):927-937. doi:10.1016/j.jchf.2021.10.002